Zerostack Corp. (ZSTK) Stock Price & Analysis
Zerostack Corp. (ZSTK) fell 5.84% to USD 1.45 as of July 25, 2026 at 15:02 UTC, according to Nexqual real-time market data.
ZSTK last closed at USD 1.54; the session ranged USD 1.44–1.55 on volume of 15,036 shares. Market capitalization is $3.52M, with a 52-week range of USD 1.37–47 (NCM). Source: Nexqual, July 25, 2026 at 15:02 UTC.
Key Statistics (as of July 25, 2026 at 15:02 UTC)
| Price | USD 1.45 |
|---|---|
| Change | ▼ 5.84% (down) |
| Previous Close | USD 1.54 |
| Open | USD 1.55 |
| Day Range | USD 1.44 – 1.55 |
| 52-Week Range | USD 1.37 – 47 |
| Volume | 15,036 shares |
| Market Cap | $3.52M |
| Exchange | NCM |
Technical Analysis (ZSTK)
Nexqual's technical model rates ZSTK "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 15:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 16.97 (oversold) |
| vs SMA50 | Below (USD 3.6) |
| MACD | -0.68 (negative) |
Analyst Ratings (ZSTK)
Wall Street analysts rate ZSTK "None" based on 1 analysts, with a mean price target of USD 11 (range USD 11–11), per Nexqual as of July 25, 2026 at 15:02 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 11 |
| High Target | USD 11 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (ZSTK)
| Revenue Estimate | $7.30M |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -34.29 vs est -0.39 ▼ miss |
| 2025-06-30 | USD -4.54 vs est -2.34 ▼ miss |
Source: Nexqual, July 25, 2026 at 15:02 UTC.
Financials & Fundamentals (ZSTK)
| Total Revenue | $36.08M |
|---|---|
| Revenue Growth (YoY) | +5.90% |
| Gross Margin | +11.81% |
| Operating Margin | -26.27% |
| Profit Margin | +0.00% |
| ROE | -730.26% |
| Debt / Equity | 9.64 |
| Current Ratio | 1.39 |
| Total Cash | $1.98M |
| Total Debt | $3.55M |
| Free Cash Flow | $-7.80M |
Source: Nexqual, July 25, 2026 at 15:02 UTC.
Financial Health Score (ZSTK)
Nexqual rates Zerostack Corp.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 15:02 UTC.
| Growth | Critical — Revenue -16% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Gross margin 12%, operating -26% |
| Balance Sheet | Strong — $2M cash vs $4M debt |
| Cash Flow | Weak — FCF negative: -$8M, burning cash |
| Efficiency | Critical — ROE -730%, ROA -22.1% |
Ownership (ZSTK)
| Insider Ownership | +276.65% |
|---|---|
| Institutional Ownership | +3.01% |
| Shares Outstanding | 2.43M |
| Float | 1.77M |
| Short % of Float | +1.79% |
Source: Nexqual, July 25, 2026 at 15:02 UTC.
Leadership (ZSTK)
Zerostack Corp. is led by Daniel Reis-Faria (age 35), CEO & Director, per Nexqual as of July 25, 2026 at 15:02 UTC.
| CEO & Director | Daniel Reis-Faria (age 35) |
|---|---|
| Executive Chairman | Michael Heinrich (age 41) |
| Chief Financial Officer | Dany Vaiman (age 39) |
| Managing Director | Manfred Ziegler (age 63) |
Major Backers & Investors (ZSTK)
Notable institutional backers of Zerostack Corp. include Fidelity, according to Nexqual as of July 25, 2026 at 15:02 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.87% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.62% |
| Geode Capital | 1.04% |
Source: Nexqual, July 25, 2026 at 15:02 UTC.
From Zerostack Corp.'s Latest SEC 10-K Filing (filed 2026-02-27)
Partnerships
- Note Private Placement On September 19, 2025, we entered into a securities purchase agreement with DeFi Development Corp, a Delaware corporation (the "Note Investor") in connection with the issuance by us to the Note Investor via a private placement (the "Note Private Placement") of an unsecured convertible note in an aggregate original principal amount of 95,333 Solana (the "Note").
- On December 29, 2025, we entered into the Note Settlement Agreement with the Note Investor pursuant to which the Note was settled.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMCC | IM Cannabis Corp. | USD 0.12 | ▼ 11.1% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| VRPX | Virpax Pharmaceuticals, Inc. | USD 0 | ▼ 75% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.46 | ▼ 1.09% |
| DBGI | Digital Brands Group, Inc. | USD 12.9 | ▼ 35.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 15:02 UTC. This page is informational and not investment advice.